news
Send us a link
An interdisciplinary team has come up with a mobile app for identifying plants based on users taking a photo of the plant on their mobile. For Citizen Science the enthusiastic engagement of the public with Flora Incognita shows a clear path forward for more widespread uses of machine learning in public participation with science and scholarship, and in knowledge creation.
Together with librarians, we’re building a new way to perform permissions checking that is backed by a modern approach and informed by a decade of experience and open, community-editable, machine-readable data.
Introducing shareyourpaper.org, the simplest way for authors to legally self-archive and for your library to fill your repository.
If you are an early career scientist looking for ways to get involved with advocacy, or a faculty member who wants to engage your students in the role of science in democracy, the Science for Public Good Fund is for you. We want to support the next generation of science advocacy leaders today.
Men reach more senior levels than women, even after parenthood is accounted for, research suggests.
The purpose of this study is to understand the familiarity and usage of metadata by those who use metadata in the process of preparing, publishing, cataloging, or sharing research papers, media and other associated objects in scholarly communications.
medRxiv aims to meet the unique preprint needs of the clinical research community with a free, non-profit service.
A team of researchers inside Pfizer made a startling find in 2015: The company’s blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug, appeared to reduce the risk of Alzheimer’s disease by 64 percent.
Changing the name on a CV affects how physics and biology faculty members view theoretical applicants, according to a new study.
Science Policy under Thatcher is the first book to examine systematically the interplay of science and government under Prime Minister Margaret Thatcher's leadership.
Resolving the question of how to provide an infrastructure for open access books and monographs has remained a persistent problem for researchers, librarians and funders. The Open Research Library aims at bringing together all available open book content onto one platform, but has been met with mixed responses.
Nobel prize winner warns UK science will suffer unless it can gain access to Horizon Europe
Asked by THE why taxpayers should not be able to immediately see the results of research they financed, Kelvin Droegemeier answered: 'They maybe should'
The Second EUA Big Deals Survey Report is an updated mapping of major scholarly publishing contracts in Europe. Conducted in 2017-2018, the report gathers data from 31 consortia covering an unprecedented 167 contracts with five major publishers: Elsevier, Springer Nature, Taylor & Francis, Wiley and American Chemical Society.
The standardized test normally required for graduate school entrance in the US is being dropped by an increasing number of science PhD programs, amid concerns about diversity and the test's predictive value.
Following a large consultation, have updated our open access (OA) policy so it now aligns with Plan S. The changes will apply from 1 January 2021.
Female animals were once deemed too hormonal and messy for science. Some scientists warn it's not enough to just use more female lab rats.
Funders behind the policy revise rules after major consultation.
A fungus has been genetically modified with spider venom to kill the mosquitoes that spread malaria.
Academics are thronging to university counselling rooms to seek help for mental health problems and stress, a report suggests.
In the aftermath of the European elections, the calculators are starting to come out in labs and universities around Europe that depend on the EU for research funding: Will it mean more or less money for science and technology? The answer so far: fuzzy maths.
MCAA and Eurodoc call on research institutions, funding bodies and governments to ensure sustainable researcher careers in a joint declaration.
In a significant escalation, policymakers are seeking to undermine or discard research showing the most dire risks of inaction on climate change.
Gene therapy achieves a milestone. Novartis will sell the world’s most expensive drug, a treatment called Zolgensma to treat spinal muscular atrophy.
Having early and rapid access to research findings accelerates the pace of science and is paramount for advancing discovery. Springer Nature considers itself ideally placed to help facilitate this and making great research available as quickly as possible to the research community.
Do Swiss researchers share their data with other researchers and with the public? And if not, why? Which data repositories and other channels do they use for data sharing? A large-scale survey by the SNSF and swissuniversities offers some answers.
The hunger for these offsets is blinding us to the mounting pile of evidence that they haven't - and won't - deliver the climate benefit they promise.
ELife announces their roadmap towards an open, scalable infrastructure for the publication of computationally reproducible articles.
